JP2013533868A5 - - Google Patents

Download PDF

Info

Publication number
JP2013533868A5
JP2013533868A5 JP2013517018A JP2013517018A JP2013533868A5 JP 2013533868 A5 JP2013533868 A5 JP 2013533868A5 JP 2013517018 A JP2013517018 A JP 2013517018A JP 2013517018 A JP2013517018 A JP 2013517018A JP 2013533868 A5 JP2013533868 A5 JP 2013533868A5
Authority
JP
Japan
Prior art keywords
diazaspiro
pyrrolo
pyrimidin
nonan
methanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013533868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2011/000080 external-priority patent/WO2012003829A1/en
Publication of JP2013533868A publication Critical patent/JP2013533868A/ja
Publication of JP2013533868A5 publication Critical patent/JP2013533868A5/ja
Pending legal-status Critical Current

Links

JP2013517018A 2010-07-09 2011-07-08 タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用 Pending JP2013533868A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36309510P 2010-07-09 2010-07-09
US61/363,095 2010-07-09
PCT/DK2011/000080 WO2012003829A1 (en) 2010-07-09 2011-07-08 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof

Publications (2)

Publication Number Publication Date
JP2013533868A JP2013533868A (ja) 2013-08-29
JP2013533868A5 true JP2013533868A5 (enExample) 2014-08-28

Family

ID=44513700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013517018A Pending JP2013533868A (ja) 2010-07-09 2011-07-08 タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用

Country Status (7)

Country Link
US (1) US9586961B2 (enExample)
EP (1) EP2590981B1 (enExample)
JP (1) JP2013533868A (enExample)
CN (1) CN102985425A (enExample)
RU (1) RU2013105450A (enExample)
TW (1) TW201204732A (enExample)
WO (1) WO2012003829A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104072499A (zh) * 2013-03-29 2014-10-01 黄传满 哌嗪取代嘧啶类化合物及其用途
CN103242321A (zh) * 2013-05-21 2013-08-14 苏州科捷生物医药有限公司 苄基哌嗪类化合物及其抗肿瘤用途
CN103396414B (zh) * 2013-07-16 2015-06-03 浙江医药高等专科学校 咪唑取代的噻唑并环己烷类化合物、及其抗肿瘤用途
MA39092B1 (fr) * 2013-12-05 2018-09-28 Pfizer Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides
AR101214A1 (es) * 2014-07-22 2016-11-30 Bayer Cropscience Ag Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas
CN105712998B (zh) * 2014-12-05 2019-12-13 上海润诺生物科技有限公司 氮杂吲哚类衍生物、其制备方法及其在医药上的应用
AU2017326487B2 (en) * 2016-09-14 2021-08-05 Janssen Pharmaceutica Nv Spiro bicyclic inhibitors of menin-MLL interaction
WO2018134352A1 (en) * 2017-01-20 2018-07-26 Leo Pharma A/S Bicyclic amines as novel jak kinase inhibitors
JP7101176B2 (ja) * 2017-02-03 2022-07-14 レオ ファーマ アクティーゼルスカブ 新規JAKキナーゼ阻害剤としての5-(7H-ピロロ[2,3-d]ピリミジン-4-イル)-5-アザスピロ[2.5]オクタン-8-カルボン酸誘導体
CN108069986B (zh) * 2017-12-08 2018-10-02 牡丹江医学院 一种治疗角膜炎的活性药物及其制备方法
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
WO2021046350A1 (en) 2019-09-05 2021-03-11 Incyte Corporation Ruxolitinib formulation for reduction of itch in atopic dermatitis
US11992490B2 (en) 2019-10-16 2024-05-28 Incyte Corporation Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
IL293965A (en) 2019-12-19 2022-08-01 Janssen Pharmaceutica Nv History of Spiro straight chain transformed

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20004727A3 (cs) * 1998-06-19 2002-03-13 Pfizer Products Inc. Deriváty pyrrolo[2,3-d] pyrimidinu
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
AU2005249380C1 (en) 2004-04-23 2012-09-20 Exelixis, Inc. Kinase modulators and methods of use
EP2049529B1 (en) 2006-07-14 2010-08-11 Merck Sharp & Dohme Corp. Substituted diazepan orexin receptor antagonists
AU2008234822A1 (en) * 2007-04-02 2008-10-09 Palau Pharma, S. A. Pyrrolopyrimidine derivatives as JAK3 inhibitors
WO2009017838A2 (en) 2007-08-01 2009-02-05 Exelixis, Inc. Combinations of jak-2 inhibitors and other agents
WO2009021169A2 (en) * 2007-08-08 2009-02-12 Lexicon Pharmaceuticals, Inc. (7h-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
MX2010008719A (es) 2008-02-06 2010-09-24 Novartis Ag Pirrolo [2,-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina.
WO2009131687A2 (en) 2008-04-22 2009-10-29 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases

Similar Documents

Publication Publication Date Title
JP2013533868A5 (enExample)
RU2013105450A (ru) Новые производные гомопиперзина в качестве ингибиторов протеинтирозинкиназ и их фармацевтическое применение
JP5918217B2 (ja) 特定のアミノピリダジン、その組成物、及びこれらの使用方法
JP2010533158A5 (enExample)
AU2015236428B2 (en) TrkA kinase inhibitors, compositions and methods thereof
JP4638355B2 (ja) チアゾール誘導体
US9493446B2 (en) Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
JP5412429B2 (ja) 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物
AU2012221828B2 (en) Imidazo[5,1-f][1,2,4]triazines for treatment of neurological disorders
JP2016523911A5 (enExample)
JP2011503166A5 (enExample)
JP2019530695A5 (enExample)
WO2012129258A1 (en) Amidopyrazole inhibitors of interleukin receptor-associated kinases
WO2017087905A1 (en) Compound, compositions, and methods
JP2008539195A (ja) 新規のオキサジアゾール誘導体及びそれらの医学的使用
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
CA2610888A1 (en) Inhibitors of akt activity
CA2554310A1 (en) Benzamide derivatives and their use as glucokinase activating agents
JP2012532152A5 (enExample)
HRP20200440T1 (hr) 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori
JP2013523884A5 (enExample)
JP2012501312A5 (enExample)
CA2693915A1 (en) Pyrazolo[1,5-a]pyrimidine derivatives
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения
JP2014511355A5 (enExample)